polatuzumab vedotin-piiq for injection,
for intravenous use Initial U.S. Approval: 2019
Polatuzumab vedotin-piiq for injection is a “used to treat lymphoma“. POLIVY for injection is a “prescription medicine. It is available in “form and strength” For injection: 140 mg of polatuzumab vedotin-piiq as a lyophilized powder in a single-dose vial. POLIVY for injection can be obtained in India upon request.
To inquire about the “offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”
Facts about your medicine
Active substance: polatuzumab vedotin-piiq
Therapeutic area: lymphoma
Marketing Authorisation: 2019.
AUTHORISED: Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here for POLIVY usage
(see Drugs@FDA for complete indication)
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
Query For Polatuzumab Vedotin-PIIQ for Injection
Know about product usage and updates
On April 19, 2023, the Food and Drug Administration approved polatuzumab vedotin-piiq with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), or high-grade B-cell lymphoma (HGBL) and who have an International Prognostic Index (IPI) score of 2 or greater.
Who is the supplier of Specialty drug in India?
Indian Pharma Network (IPN) Legitimate consultant and facilitator for Specialty drugs in India. IPN, Delhi can assist you in connecting with prospective distributors, wholesalers, suppliers, and dealers of POLIVY (polatuzumab vedotin-piiq) for injection. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.
POLIVY (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 2019
Related posts for product review usage
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa